DNA methylation biomarker for prostate cancer shows promise for accurately determining patient risk
Philadelphia, PA, Dec. 8, 2016 - Prostate-specific antigen (PSA) and other biomarkers are essential tools for diagnosing and monitoring prostate cancer. However, biomarkers to selectively...